Alkermes plc. (ALKS): Revenue
$1.48B
Year ended 2025-12-31
$1.67B
Trailing 12 months to 2026-06-30
+9.9%
3-year compound annual growth
+7.3%
5-year compound annual growth
+8.9%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.48B | -5.2% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $1.56B | -6.4% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $1.66B | +49.6% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $1.11B | -5.3% | 2025-02-12, From 2022-01-01 |
| 2021-12-31 | $1.17B | +13.0% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $1.04B | -11.3% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $1.17B | +7.0% | 2022-02-16, From 2019-01-01 |
| 2018-12-31 | $1.09B | +21.1% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $903.37M | +21.1% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $745.69M | +18.7% | 2019-02-15, From 2016-01-01 |
| 2015-12-31 | $628.34M | +1.5% | 2018-02-16, From 2015-01-01 |
| 2014-12-31 | $618.79M | +3.8% | 2017-02-17, From 2014-01-01 |
| 2013-12-31 | $596.33M | n/a | 2016-02-25, From 2013-01-01 |
| No annual figure between 2012-03-31 and 2013-12-31. | |||
| 2012-03-31 | $389.98M | +108.9% | 2013-05-23, From 2011-04-01 |
| 2011-03-31 | $186.64M | +4.7% | 2013-05-23, From 2010-04-01 |
| 2010-03-31 | $178.28M | n/a | 2012-05-18, From 2009-04-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Alkermes plc. (ALKS) | 2025-12-31 | $1.48B | -5.2% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $1.52B | +17.1% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $1.73B | +114.5% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $1.24B | +4.3% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $1.09B | -4.3% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $1.07B | +11.9% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $2.20B | +15.6% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $958.40M | +432.1% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $943.71M | +33.8% |
Compare ALKS, PAHC, PTCT, INDV side by side · Screen every company in Pharmaceutical Preparations ↗